Portal de Periódicos da CAPES

Watch and wait approach in rectal cancer: Current controversies and future directions

2020; Baishideng Publishing Group; Volume: 26; Issue: 29 Linguagem: Inglês

10.3748/wjg.v26.i29.4218

2219-2840

Fernando López‐Campos, M. Martín, R. Fornell Pérez, Juan Carlos García Pérez, Javier Díe Trill, Raquel Fuentes-Mateos, Sergio López-Durán, José Antonio Domínguez-Rullán, Reyes Ferreiro, Alejandro Riquelme-Oliveira, A. Hervás, Felipe Couñago,

Colorectal Cancer Screening and Detection

According to the main international clinical guidelines, the recommended treatment for locally-advanced rectal cancer is neoadjuvant chemoradiotherapy followed by surgery. However, doubts have been raised about the appropriate definition of clinical complete response (cCR) after neoadjuvant therapy and the role of surgery in patients who achieve a cCR. Surgical resection is associated with significant morbidity and decreased quality of life (QoL), which is especially relevant given the favourable prognosis in this patient subset. Accordingly, there has been a growing interest in alternative approaches with less morbidity, including the organ-preserving watch and wait strategy, in which surgery is omitted in patients who have achieved a cCR. These patients are managed with a specific follow-up protocol to ensure adequate cancer control, including the early identification of recurrent disease. However, there are several open questions about this strategy, including patient selection, the clinical and radiological criteria to accurately determine cCR, the duration of neoadjuvant treatment, the role of dose intensification (chemotherapy and/or radiotherapy), optimal follow-up protocols, and the future perspectives of this approach. In the present review, we summarize the available evidence on the watch and wait strategy in this clinical scenario, including ongoing clinical trials, QoL in these patients, and the controversies surrounding this treatment approach.